Search Results

"VIPREG2024 1xbet registration promo code 2024 Malaysia"

Introduction
The Cancer Atlas aims to open readers’ eyes to the global scale and impact of cancer, covering the extent and magnitude of the disease, the major causes, and the different ways the disease can be prevented and treated. As with previous editions, this fourth edition of The Cancer Atlas is1
Cancer in Latin America and the Caribbean
The Latin America and the Caribbean (LAC) region has doubled in population size over the last half-century to 665 million inhabitants today. About 1.5 million new cancer cases and 741,000 cancer deaths, excluding non-melanoma skin cancers, are estimated to occur in the LAC region in 2022. The five most common1
Cancer in Northern Africa, Central and West Asia
Northern Africa, Central and West Asia is a diverse region characterized by relatively low but increasing cancer incidence rates. Breast cancer is the most common cancer in both sexes combined in all countries but Egypt (liver cancer), Kyrgyzstan and Tajikistan (stomach cancer), and Azerbaijan, Armenia, Tunisia, Türkiye (lung cancer) (Map1
Social Inequalities
With sufficient investment, cancer prevention can mitigate the marked cancer inequalities that exist between and within countries worldwide. Health inequalities refer to differences in people’s health that are unjust and avoidable (Figure 13.1) and may relate to differences between groups based on, among others, socioeconomic position, race or ethnicity, sex, disability,1
About The Atlas
The continuing and escalating global fight against cancer demands new tools and the latest available data and trends. The Cancer Atlas website and The Cancer Atlas, Fourth Edition book – produced by the American Cancer Society and the International Agency for Research on Cancer – provide a comprehensive global overview1
Human Carcinogens
The IARC Monographs identify the causes of human cancer. Sometimes called the World Health Organization’s “Encyclopedia of Carcinogens,” the IARC Monographs are systematic evaluations of the strength of evidence that an agent can cause cancer in humans. Since the program’s inception in 1971, over 1,040 agents have been evaluated, including1
Building Synergies
Global cancer control requires a coordinated response from national governments, researchers, funders, practitioners, advocates, patients, and international organizations. Multiple high-level resolutions have called for reduced cancer mortality, but work remains to meet targets and understand what approaches work best, especially in low- and middle-income countries (LMICs), where burden is increasing.1
Global Relay For Life
What started with one person in the US in 1985 to raise money and awareness has become a true global movement against cancer, uniting people in 35 countries (Figure 44.1) to do what no one country or organization can do alone: build a world free from cancer. Across the globe,1